MOLECULAR HETEROGENEITY OF KINASE INHIBITOR RESISTANCE MECHANISMS IN GASTROINTESTINAL STROMAL TUMORS
Ravegnini G., Angelini S., Hrelia P., Fletcher J. |
ASSESSMENT IN THE HUMAN PLATELET TRANSCRIPTOME OF A PREDICTIVE SIGNATURE OF THE CORONARY ARTERY DISEASE TYPE.
Camera M., Colombo G., Brambilla M., Piacentini L., Rossetti L., Canzano P., Trabattoni D., Teruzzi G., Rubino M., Marenzi G., Tremoli E. |
DEVELOPMENT AND VALIDATION OF A PHARMACOGENETIC TEST FOR CORRECT MANAGEMENT OF HCV PATIENTS TREATED WITH PEGYLATED-INTERFERON (PEGINF) PLUS RIBAVIRIN (RBV)
Bugin E., Bortolozzo K., Ragazzi E. |
PREDICTING STEADY STATE DONEPEZIL PLASMA CONCENTRATIONS IN PATIENTS WITH ALZHEIMER DISEASE THROUGH CLINICAL CHARACTERISTICS AND HEPATIC CYTOCHROME PHENOTYPE
Groppa F., Granziera S., Coin A., De Rosa G., Bertolaso L., Gusella M., De Rui M., Girardi A., Pamio M., Sergi G., Manzato E., Padrini R. |
MTHFR-1298A>C IS A PREDICTOR OF SURVIVAL IN STAGE II/III COLORECTAL CANCER TREATED WITH ADJUVANT FLUOROPYRIMIDINE CHEMOTHERAPY WITH OR WITHOUT OXALIPLATIN
Perrone G., Cecchin E., Nobili S., Polesel J., De Mattia E., Zanusso C., Petreni P., Lonardi S., Pella N., D'Andrea M., Errante D., Rizzolio F., Mazzei T., Landini I., Mini E., Toffoli G. |
A HIGH COMT ACTIVITY HAPLOTYPE PREDISPOSES PATIENTS WITH MEDICATION OVERUSE HEADACHE TO A LOWER RISK OF RELAPSE AFTER SUCCESSFUL WITHDRAWAL TREATMENT
Terrazzino S., Cargnin S., Viana M., Ghiotto N., Sances G., Nappi G., Canonico P., Genazzani A. |
GSTM1 AND GSTT1 POLYMORPHISMS IN POPULATION-BASED STUDY OF COLORECTAL CANCER RISK
Rizzolio F., Giusti P., Toffoli G., Boffo S. |
EVALUATION OF THE ROLE OF THE ESTROGEN RECEPTOR SPLICING ISOFORMS IN THE PHARMACOLOGICAL RESPONSE TO ENDOXIFEN TREATMENT IN BREAST CANCER MODELS
Bertolaso L., Pezzolo E., Zhao C., Padrini R., Dahlman-Wright K., Pasini F., Gusella M. |
